Our Perspectives
THREAD Blog
How Rare Diseases Were Affected by the COVID Pandemic
The latest issue of Raconteur (published as a supplement in The Times, UK) took a deep look at the rare disease landscape, including how rare diseases were affected by the COVID pandemic, and how patients who are engaged in the drug development process through clinical trials can build connections through digital platforms.
How to Scale Successful Decentralized Clinical Trials
When evaluating how to maximize trial success, especially given the growth of DCT methodology, scaling studies on a global level provides significant opportunity to enhance health outcomes and improve study timelines in the life sciences industry.
Decentralized Clinical Trial Tools that Increase Patient Retention
Sponsors and CROs alike understand the potential to bring trials out of the clinic and to geographically dispersed patients for better recruitment, retention and trial success. Decentralized clinical trials (DCTs) are becoming one of the most dynamic ways to expand clinical research opportunities and health outcomes globally.
A look into the hyper-acceleration of life sciences with Sean Vassilaros
We are obviously concerned about the safety and efficacy of clinical research, but we also want to make sure we are going down the right path when it comes to the goal of life sciences: taking care of the patient. In fact, Sean Vassilaros, COO of THREAD uses the phrase, ‘appropriate-effort’ to discuss the matter when asked how he believed this process was able to be expedited. "We just learned in the last year, that if you use appropriate effort to bring something to production, you're allowed to move at lightning speed."